Welcome to GRACE






    Home

    Overview

    Confidentiality

    Bibliography

    Advisors

    Resources

    Members Room



    
   

GRACE Bibliography -

Easily printable version (requires Adobe Acrobat)
GRACE Appendix (requires Adobe Acrobat)
Manuscripts
Non-GRACE publications
‘Expanded’ GRACE publications
Abstracts

Manuscripts
2010
  1. Buysschaert I, Carruthers KF, Dunbar DR, Peuteman G, Rietzschel E, Belmans A, Hedley A, De Meyer T, Budaj A, Van de Werf F, Lambrechts D, Fox KAA. A variant at chromosome 9p21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome: The GRACE Genetics Study. Eur Heart J 2010 (in press).
  2. Chew DP, Anderson FA, Avezum A, Eagle KA, FitzGerald G, Gore JM, Dedrick R, Brieger D, on behalf of the GRACE Investigators. Six-Month Survival Benefits associated with clinical guideline recommendations in acute coronary syndromes. Heart 2010 (in press).
  3. Fox FAA, Carruthers K, Steg PhG, Avezum Á, Granger CB, Montalescot G, Goodman SG, Gore JM, Quill AL, Eagle KA, for the GRACE Investigators. Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The Global Registry of Acute Coronary Events. Eur Heart J 2010; 31(6):667–67.
  4. Fox KAA, Eagle KA, Gore JM, Steg PhG, Anderson FA, for the GRACE and GRACE2 Investigators. The Global Registry of Acute Coronary Events, 1999 to 2009 – GRACE. Heart 2010 (in press).
  5. López-Sendón J, Gurfinkel EP, Lopez de Sa E, Agnelli G, Gore JM, Steg PhG, Eagle KA, Ruiz Cantador J, FitzGerald G, Granger CB, and for the Global Registry of Acute Coronary Events (GRACE) Investigators. Factors related to heart rupture in acute coronary syndromes in the Global Registry of Acute Coronary Events. Eur Heart J 2010 doi:10.1093/eurheartj/ehq061.
  6. Nguyen HL, Goldberg RG, Gore JM, Fox KAA, Eagle KA, Gurfinkel EP, Spencer FA, Reed G, Quill A, Anderson FA. Age and Sex Differences, and Changing Trends, in the Use of Evidence-Based Therapies in Acute Coronary Syndromes: Perspectives from a Multinational Registry. Coron Art Dis Dis 2010 (in press).
  7. Spencer FA, Montalescot G, Fox KAA, Goodman SGG, Granger CB, Goldberg RJ, Oliveira GBF, Anderson FA, Eagle KA, FitzGerald G, Gore JM, and for the Global Registry of Acute Coronary Events (GRACE) Investigators. Delay to reperfusion in patients with acute myocardial infarction presenting to acute care hospitals. An international perspective. Eur Heart J (2010)doi: 10.1093/eurheartj/ehq057.
2009
  1. Ambrosio G, Del Pinto M, Tritto I, Agnelli G , Bentivoglio M, Zuchi C, Fox KAA, Anderson FA, Gore JM, López-Sendón J, Wyman A, Kennelly BM; for the GRACE investigators. Chronic Nitrate Therapy is Associated with Different Presentation and Evolution of Acute Coronary Syndromes: Insights from 52,693 Patients in the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2009. doi:10.1093/eurheartj/ehp457.
  2. Avezum Á, Piegas LS, Goldberg RJ, Brieger D, Stiles MK, Paolini R, Huang W, Gore JM, for the GRACE Investigators. Magnitude and prognosis associated with ventricular arrhythmias in patients hospitalized with acute coronary syndromes (from the GRACE registry). Am J Cardiol; 102(12):1577-82.
  3. Brieger D, Fox KAA, FitzGerald G, Eagle KA, Budaj A, Avezum Á, Granger CB, Costa B, Anderson FA, Steg PG, for the GRACE Investigators. Predicting freedom from clinical events in non–ST-elevation acute coronary syndromes. The Global Registry of Acute Coronary Events. Heart 2009;95:888-94.
  4. Dey S, Flather MD, Devlin G, Brieger D, Gurfinkel EP, Steg PG, FitzGerald G, Jackson EA, Eagle KA. Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events. Heart 2009;95(1):20-6. [published online in 2008]
  5. Goldberg RG, Spencer FA, Fox KAA, Brieger D, Steg PG, Gurfinkel EP, Dedrick R, Gore JM. Pre-hospital Delay in Patients with Acute Coronary Syndromes (from the GRACE Registry). Am J Cardiol 2008. [published online DOI: 10.1016/j.amjcard.2008.10.038]
  6. Gore JM, Spencer FA, Gurfinkel EP, Lopez-Sendon J, Steg PG, Granger CB, et al. Thrombocytopenia in patients with an acute coronary syndrome (from the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol 2009;103(2):175-80.
  7. LaBounty T, Gurm HS, Goodman SG, Montalescot G, Lopez-Sendon J, Quill A, Eagle KA, for the GRACE Investigators. Predictors and implications of Q-waves in ST-elevation acute coronary syndromes. Am J Med 2009;122:144-51.
  8. López-Sendón J, Dabbous OH, López de Sá E, Stiles M, Gore JM, Brieger D, Van de Werf F, Budaj A, Gurfinkel EP, Fox KAA, on behalf of the GRACE investigators. Hospital outcomes associated with fibrinolytic drugs and thienopyridines in patients with ST-segment elevation acute myocardial infarction. The Global Registry of Acute Coronary Events. Rev Esp Cardiol. 2009;62:501-509.
  9. Medi C, Montalescot G, Budaj A, Fox KAA, López-Sendón J, FitzGerald G, Brieger DB, on behalf of the GRACE Investigators. Reperfusion in Patients with Renal Dysfunction after Presentation with ST Elevation or Left Bundle Branch Block. The Global Registry of Acute Coronary Events. J Am Coll Cardiol Intv 2009;2:26–33.
  10. Montalescot G, Brieger D, Eagle KA, Anderson FA, Jr., Fitzgerald G, Lee MS, Steg PG, Avezum A, Goodman SG, Gore JM. Unprotected left main revascularization in patients with acute coronary syndromes. Eur Heart J. 2009. 10.1093/eurheartj/ehp353
  11. Pieper KS, Gore JM, FitzGerald G, Granger CB, Goldberg RJ, Steg G, Eagle KA, Anderson FA, Budaj A, Fox KA. Validity of a risk-prediction tool for hospital mortality: the Global Registry of Acute Coronary Events. Am Heart J. 2009;157:1097-1105.
  12. Ruisi CP, Goldberg RJ, Kennelly BM, Goodman SG, Lopez-Sendon J, Granger CB, Avezum A, Eagle KA, FitzGerald G, Gore JM, on behalf of the GRACE investigators. Pulmonary artery catheterization in patients with acute coronary syndromes. Am Heart J 2009;158:170-6.
  13. Sinnaeve PR, Steg PG, Fox KAA, Van de Werf F, Montalescot G, Granger CB, Knobel E, Anderson FA, Dabbous OH, Avezum Á, for the GRACE Investigators. Elevated fasting glucose is associated with increased short-term and 6-month mortality in ST- and non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary Events. Arch Intern Med 2009;169(4):402-409.
  14. Steg PG, FitzGerald G, Fox KAA. Risk stratification in non–ST-segment elevation acute coronary syndromes: troponin is not enough. Am J Med 2009;122:107-08.
  15. Steg P Gabriel, Fox KA, Eagle KA, Furman M, Van de Werf F, Montalescot G, et al. Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events. Eur Heart J 2009.
  16. Swanson N, Montalescot G, Eagle KA, Goodman S, Huang W, Brieger D, Devlin GP. Delay to angiography and outcomes following presentation with high-risk, non-ST elevation acute coronary syndromes (NSTE-ACS). Results from the Global Registry of Acute Coronary Events. Heart 2008;0: hrt.2008.149922v1.
  17. Vedre A, Gurm HS, Froehlich JB, Kline-Rogers E, Montalescot G, Gore JM, Brieger D, Quill AL, Eagle KA, for the GRACE Investigators. Impact of prior statin therapy on arrhythmic events in patients with acute coronary syndromes (From the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol 2009;104:1613-1617.
  18. Yan AT, Steg PhG, FitzGerald G, Feldman LJ, Eagle KA, Gore JM, Anderson FA, López-Sendón J, Gurfinkel EP, Brieger D, Goodman SG, for the GRACE Investigators. Recurrent Ischemia Across the Spectrum of Acute Coronary Syndromes: Prevalence and Prognostic Significance of (Re-)Infarction and ST-segment Changes in a Large Contemporary Registry. Int J Cardiol. 2009; May 27. [Epub ahead of print].

2008

  1. Dabbous OH, Anderson FA, Jr., Gore JM, Eagle KA, Fox KA, Mehta RH, Goldberg RJ, Agnelli G, Steg PG. Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes. Heart 2008;94:159-65.
  2. Devlin G, Gore JM, Elliott J, Wijesinghe N, Eagle KA, Avezum A, Huang W, Brieger D. Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary Events. Eur Heart J 2008;29:1275-1282.
  3. Eagle KA, Nallamothu BK, Mehta RH, Granger CB, Steg PG, Van de Werf F, López-Sendón J, Goodman SG, Quill A, Fox KAA, for the Global Registry of Acute Coronary Events (GRACE) Investigators. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur Heart J 2008;29:609-617.
  4. Fox KA, Anderson FA, Jr, Goodman SG, Steg PG, Pieper K, Quill A, Gore JM. Time course of events in acute coronary syndromes: implications for clinical practice from the GRACE registry. Nat Clin Pract Cardiovasc Med 2008;5:580-9.
  5. Steg PG, Kerner A, Van de Werf F, Lopez-Sendon J, Gore JM, Fitzgerald G, Feldman LJ, Anderson FA, Avezum A. Impact of in-hospital revascularization on survival in patients with non-ST-elevation acute coronary syndrome and congestive heart failure. Circulation 2008;118:1163-71.
  6. Stiles MK, Dabbous OH, Fox KA. Bleeding Events with Antithrombotic Therapy in Patients with Unstable Angina or non-ST-segment Elevation Myocardial Infarction; Insights from a Large Clinical Practice Registry (GRACE). Heart Lung Circ 2008;17:5-8.
  7. Yan RT, Yan AT, Granger CB, Lopez-Sendon J, Brieger D, Kennelly B, Budaj A, Steg PhG, Georgescu AA, Hassan Q, Goodman SG, on behalf of the Global Registry of Acute Coronary Events (GRACE) Electrocardiogram Substudy Group. Usefulness of quantitative versus qualitative ST-segment depression for risk stratification of non-ST elevation acute coronary syndromes in contemporary clinical practice. Am J Cardiol 2008;101:919–924

2007

  1. Brieger D, Elsik M, Gore JM, Knobel E, Nussbacher A, Piegas LS, Allegrone J, Anderson FA, Avezum Á, on behalf of the Global Registry of Acute Coronary Events investigators. Predicting coronary artery bypass graft surgery in acute coronary syndromes. EuroIntervention 2007;2:452–458.
  2. Brieger D, Van de Werf F, Avezum Á, Montalescot G, Kennelly BM, Granger CB, Goodman SG, Dabbous OH, Agnelli G, for the GRACE Investigators. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events. Am Heart J 2007;153:960-9.
  3. Fox KAA, Anderson Jr FA, Dabbous OH, Steg PhG, López-Sendón J, Van de Werf F, Budaj A, Gurfinkel EP, Goodman SG, Brieger D, on behalf of the GRACE Investigators. Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE). Heart 2007;93:177-82.
  4. Fox KAA, Steg PG, Eagle KA, Goodman SG, Anderson FA, Granger CB, Flather MD, Budaj A, Quill A, Gore JM, for the GRACE Investigators. Decline in rates of death and heart failure in acute coronary syndromes, 1999 to 2006. JAMA 2007;297:1892-1900.
  5. Gore JM, Spencer FA, Goldberg RJ, Kennelly BM, Fox KAA, Allegrone J, Eagle KA, Anderson FA, Steg PG, on behalf of the GRACE Investigators. Use of heparins in non-ST-elevation acute coronary syndromes. Am J Med 2007:120:63-71.
  6. Goldberg RJ, Spencer FA, Steg PG, Flather MD, Montalescot G, Gurfinkel EP, Kennelly BM, Goodman SG, Dedrick R, Gore JM, for the GRACE Investigators. Increasing use of single and combination medical therapy in patients hospitalized for acute myocardial infarction in the 21st century: a multinational perspective. Arch Intern Med 2007;167:1766-1773.
  7. Gurfinkel EP, Perez de la Hoz R, Brito VB, Duronto E, Dabbous OH, Gore JM, Anderson FA, for the GRACE Investigators. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery. Int J Cardiol 2007; 119:65-72.
  8. Mukherjee D, Eagle KA, Kline-Rogers E, Feldman LJ, Juliard JM, Agnelli G, Budaj A, Avezum Á, Allegrone J, FitzGerald G, Steg PG, on behalf of the GRACE Investigators. Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events). Am J Cardiol 2007;100:1-6.
  9. Nallamothu BK, Fox KAA, Kennelly BM, Van de Werf F, Gore JM, Steg PG, Granger CB, Dabbous OH, Kline-Rogers E, Eagle KA, on behalf of the GRACE Investigators. Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events. Heart 2007 doi:10.1136/hrt.2006.112847.
  10. Nguyen MC, Lim YL, Walton A, Lefkovits J, Agnelli G, Goodman SG, Budaj A, Gulba DC, Allegrone J, Brieger D, for the GRACE Investigators. Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent? Eur Heart J 2007. doi:10.1093/eurheartj/ehm186.
  11. Oliveira GBF, Avezum Á, Frederick FA, Budaj A, Dabbous OH, Goodman SG, Steg PG, Goldberg RJ, Brieger D, Fox KAA, Gore JM, Granger CB, for the GRACE Investigators. Use of proven therapies in non–ST-elevation acute coronary syndromes according to evidence-based risk stratification. Am Heart J 2007;153:493-9.
  12. Ramsay G, Podogrodzka M, McClure C, Fox KAA. Risk prediction in patients presenting with suspected cardiac pain: the GRACE and TIMI risk scores versus clinical evaluation. QJM 2007 100(1):11-18; doi:10.1093/qjmed/hcl133.
  13. Spencer FA, Goldberg RJ, Gore JM, Fox KAA, Avezum Á, Agnelli G, Kritharides L, Anderson FA, Goodman SG, FitzGerald G, Allegrone J, Brieger D, for the GRACE Investigators. Comparison of utilization of statin therapy at hospital discharge and 6-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein =100 mg/dl versus <100 mg/dl. Am J Cardiol 2007;100:913–918.
  14. Spencer FA, Moscucci M, Granger CB, Gore JM, Goldberg RJ, Steg PG, Goodman SG, Budaj A, FitzGerald G, Fox KAA, for the GRACE Investigators. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation 2007;116:2793-801.
  15. Steg PG, López-Sendón J, Lopez de Sa E, Goodman SG, Gore JM, Anderson FA, Himbert D, Allegrone J, Van de Werf F, for the GRACE Investigators. External validity of clinical trials in acute myocardial infarction. Arch Intern Med 2007;167:68-73.
  16. Yan RT, Yan AT, Allegrone J, López-Sendón J, Granger CB, Gore JM, Budaj A, Georgescu AA, Hassan Q, Luchansky J, Van de Werf F, Goodman SG, on behalf of the Global Registry of Acute Coronary Events (GRACE) Electrocardiogram Substudy Group. Differences between local hospital and core laboratory interpretation of the admission electrocardiogram in patients with acute coronary syndromes and their relation to outcome. Am J Cardiol 2007;100:169-74.
  17. Yan A, Yan RT, Goodman SG, Kennelly BM, Anderson Jr., Budaj A, López-Sendón J, Brieger D, Allegrone J, Steg PG, Goodman SG, for the GRACE Investigators. Relationship of ST elevation in lead aVR with angiographic findings and outcome in non-ST elevation acute coronary syndromes. Am Heart J 2007;154:71-8.
2006
  1. Emery M, López-Sendón J, Steg PG, Anderson FA, Jr., Dabbous OH, Scheuble A, Eagle KA. Patterns of use and potential impact of early beta-blocker therapy in non-ST-elevation myocardial infarction with and without heart failure: the Global Registry of Acute Coronary Events. Am Heart J 2006;152:1015-1021.
  2. Fox KAA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, Avezum Á, Goodman SG, Flather MD, Anderson Jr, FA, Granger CB, for the GRACE Investigators. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). Br Med J 2006;333:1091-4. doi:10.1136/bmj.38985.646481.55 (published 10 October 2006)
  3. Froehlich JB, Mukherjee D, Avezum Á, Budaj A, Kline-Rogers EM, López-Sendón J, Agnelli G, Allegrone J, Eagle KA, Mehta RH, Goldberg RJ, for the GRACE Investigators. Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Am Heart J 2006;151:1123-8.
  4. Goodman SG, Steg PG, Eagle KA, Fox KAA, López-Sendón J, Montalescot G, Budaj A, Kennelly BM, Gore JM, Allegrone J, Granger CB, Gurfinkel EP, for the GRACE Investigators. The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2006;151:654-60.
2005
  1. Avezum Á, Makdisse M, Spencer F, Gore JM, Fox KAA, Montalescot G, Eagle KA, White K, Mehta RH, Knobel E, Collet J-P, for the GRACE Investigators. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2005;149:67-73.
  2. Budaj A, Flasinska K, Gore JM, Anderson FA, Dabbous OH, Spencer FA, Goldberg RJ, Fox KAA, on behalf of the GRACE Investigators. Magnitude of and risk factors for stroke in patients with acute coronary syndromes. Findings from a Global Registry of Acute Coronary Events. Circulation 2005; 111:3242-7.
  3. Carruthers KF, Dabbous OH, Flather MD, Starkey I, Jacob A, MacLeod D, Fox KAA, on behalf of the GRACE Investigators. Contemporary management of acute coronary syndromes: does the practice match the evidence? The Global Registry of Acute Coronary Events (GRACE). Heart 2005;91:290-8.
  4. Collet JP, Montalescot G, Agnelli G, Van de Werf F, Gurfinkel EP, López-Sendón J, Laufenberg CV, Klutman M, Gowda N, Gulba D, for the GRACE Investigators. Non-ST-segment elevation acute coronary syndrome in patients with renal failure in the Global Registry of Acute Coronary Events: benefit of low-molecular-weight heparin alone and with glycoprotein IIb/IIIa inhibitors on outcomes. Eur Heart J 2005; doi:10.1093/eurheartj/ehj337.
  5. Devlin GP, Anderson Jr FA, Heald S, López-Sendón J, Avezum Á, Elliott J, Dabbous OH, and Brieger D. Management and outcomes of lower-risk patients presenting with acute coronary syndromes in a multinational observational registry. Heart 2005; doi:10.1136/hrt.2004.054007
  6. Granger CB, López-Sendón J, Van de Werf F, Kline-Rogers E, Anderson FA, Dabbous OH, Allegrone J, Klein W, Eagle KA. Medication performance measures and mortality following acute coronary syndromes. Am J Med 2005;118:858-65.
  7. Gurfinkel EP, Bozovich GE, Dabbous O, Mautner B, Anderson F. Socio economic crisis and mortality. Epidemiological testimony of the financial collapse of Argentina. Thromb J. 2005;3:22.
  8. Himbert D, Klutman M, Steg PhG, White K, Gulba DC, for the GRACE Investigators. Cigarette smoking and acute coronary syndromes: a multinational observational study. Int J Cardiol 2005; 100:109-17.
  9. Lim MJ, Eagle KA, Gore JM, Goldberg RJ, Mehta RJ, Granger CB, Anderson FA, Flather M, Dabbous OH, Spencer FA. Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events). Am J Cardiol 2005;96:917-21.
  10. Lim MJ, Spencer FA, Gore JM, Dabbous OH, Agnelli G, Kline-Rogers EM, DiBenedetto D, Eagle KA, Mehta RH, for the GRACE Investigators. Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes. Perspectives from a large multinational registry. Eur Heart J 2005; doi: 10.1093/eurheartj/ehi139.
  11. Mallat Z, Steg PG, Benessiano J, Tanguy ML, Fox KA, Collet JP, Dabbous OH, Henry P, Carruthers KF, Dauphin A, Arguelles CS, Masliah J, Hugel B, Montalescot G, Freyssinet JM, Asselain B, Tedgui A. Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes. J Am Coll Cardiol 2005;46:1249-1257.
  12. Montalescot G, Dabbous OH, Lim MJ, Flather MD, Mehta RH, for the GRACE Investigators. Relation of timing of cardiac catheterization to outcomes in patients with non-ST-segment elevation myocardial infarction or unstable angina pectoris enrolled in the multinational Global Registry of Acute Coronary Events. Am J Cardiol 2005; 95:1397-1403.
  13. Van de Werf F, Gore JM, Avezum Á, Gulba DC, Goodman SG, Budaj A, Brieger D, White K, Fox KAA, Eagle KA, Kennelly BM, and for the GRACE Investigators. Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study. Br Med J 2005;330:441.
2004
  1. Brieger D, Eagle KA, Goodman SG, Steg PhG, Budaj A, White K, Montalescot G, for the GRACE Investigators. Acute coronary syndromes without chest pain: an underdiagnosed and undertreated high-risk group. Insights from the Global Registry of Acute Coronary Events (GRACE). Chest 2004;126:461-69.[Medline] [Free full text]
  2. Eagle KA, Kline-Rogers E, Goodman SG, Gurfinkel EP, Avezum Á, Flather MD, Granger CB, Erickson S, White K, Steg PhG, for the GRACE Investigators. Adherence to evidence-based therapies after discharge for acute coronary syndromes. An ongoing, prospective, observational study. Am J Med 2004;117:73-81.
  3. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, Goodman SG, Granger CB, Steg PG, Gore JM, Budaj A. Avezum Á, Flather MD, Fox KAA, for the GRACE Investigators. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. J Am Med Assoc 2004;291:2727-33.
  4. Fox KAA. An international perspective on acute coronary syndrome care. Insights from the Global Registry of Acute Coronary Events. Am Heart J 2004;148:S40-5.
  5. Franklin K, Goldberg RJ, Spencer F, Klein W, Budaj A, Brieger D, Marre M, Steg PhG, Gowda N, Gore JM, for the GRACE Investigators. Implications of diabetes in patients with acute coronary syndromes: the Global Registry of Acute Coronary Events. Arch Intern Med 2004;164:1457-63.
  6. Furman MI, Gore JM, Anderson FA, Budaj A, Goodman SG, Avezum Á, López-Sendón J, Klein W, Mukherjee D, Eagle KA, Dabbous OH, Goldberg RJ, for the GRACE Investigators. Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2004;147:42-8.
  7. Goldberg RJ, Currie K, White K, Brieger D, Steg PhG, Goodman SG, Dabbous O, Fox KAA, Gore JM. Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol 2004;93:288-93.
  8. Mehta RH, Sadiq I, Goldberg RJ, Gore JM, Avezum Á, Spencer F, Kline-Rogers E, Allegrone J, Pieper K, Fox KAA, Eagle KA, for the GRACE Investigators. Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarction. Am Heart J 2004;147:253-9.
  9. Spencer FA, Allegrone J, Goldberg RJ, Gore JM, Fox KAA, Granger CB, Mehta RH, Brieger D, for the GRACE Investigators. Association of statin therapy with outcomes of acute coronary syndromes: The GRACE Study. Annal Int Med 2004;140:857-66.
  10. Steg PhG, Dabbous OH, Feldman LJ, Cohen-Solal A, Aumont M-C, López-Sendón J, Budaj A, Goldberg RJ, Klein W, Anderson FA, for the Global Registry of Acute Coronary Events (GRACE) Investigators. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Circulation 2004;109:494-9.
2003
  1. Budaj A, Brieger D, Steg PhG, Goodman SG, Dabbous OH, Fox KAA, Avezum Á, Cannon CP, Mazurek T, Flather MD, Van de Werf F, for the GRACE Investigators. Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2003;146:999-1006. [Summary]
  2. Fox KAA, Goodman SG, Anderson FA, Granger CB, Moscucci M, Flather MD, Spencer F, Budaj A, Dabbous OH, Gore JM, on behalf of the GRACE Investigators. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003;24:1414-24.
  3. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van de Werf F, Avezum Á, Goodman SG, Flather MD, Fox KAA, for the Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the Global Registry of Acute Coronary Events. Arch Intern Med 2003;163:2345-53.
  4. Klein W, Kraxner W, Hödl R, Steg PhG, Budaj A, Gulba D, Sadiq I, Van de Werf F, White K, Fox KAA, for the GRACE investigators. Patterns of use of heparins in ACS. Correlates and hospital outcomes: the Global Registry of Acute Coronary Events (GRACE). Thromb Haemost 2003;90:519-27.
  5. Mehta RH, Dabbous OH, Granger CB, Kuznetsova P, Kline-Rogers EM, Anderson FA Jr, Fox KAA, Gore JM, Goldberg RJ, Eagle KA, for the GRACE Investigators. Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am J Cardiol 2003;92:1031-6.
  6. Montalescot G, Van de Werf F, Gulba DC, Avezum Á, Brieger D, Kennelly BM, Mazurek T, Spencer F, White K, Gore JM, for the GRACE Investigators. Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: findings from the Global Registry of Acute Coronary Events (GRACE). Catheter Cardiovasc Interv 2003;60:360-7.
  7. Moscucci M, Fox KAA, Cannon CP, Klein W, López-Sendón J, Montalescot G, White K, Goldberg RJ, for the GRACE Investigators. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003;24:1815-23.
  8. Santopinto JJ, Fox KAA, Goldberg RJ, Budaj A, Piñero G, Avezum Á, Gulba D, Esteban J, Gore JM, Johnson J, Gurfinkel EP, on behalf of the GRACE Investigators. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE). Heart 2003;89:1003-8.
2002
  1. Dauerman HL, Goldberg RJ, White K, Gore JM, Sadiq I, Gurfinkel E, Budaj A, Lopez de Sa E, López-Sendón J, for the GRACE Investigators. Revascularization, stenting, and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol 2002;90:838-42.
  2. Eagle K. Lessons from GRACE: the Global Registry of Acute Coronary Events. Eur Heart J 2002;4(Suppl E):E24-31.
  3. Eagle KA, Goodman SG, Avezum Á, Budaj A, Sullivan CM, López-Sendón J, for the GRACE Investigators. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002;359:373-7.
  4. Fox KAA, Goodman SG, Klein W, Brieger D, Steg PhG, Dabbous O, Avezum Á, for the GRACE Investigators. Management of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2002;23:1177-89.
  5. Goldberg RJ, Steg PhG, Sadiq I, Granger CB, Jackson EA, Budaj A, Brieger D, Avezum Á, Goodman S. Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry). Am J Cardiol 2002;89:791-6.
  6. Spencer F, Santopinto J, Gore JM, Goldberg RJ, Fox KAA, Moscucci M, White K, Gurfinkel EP. Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol 2002;90:1056-61.
  7. Steg PhG, Goldberg RJ, Gore JM, Fox KAA, Eagle KA, Flather MD, Sadiq I, Kasper R, Rushton-Mellor SK, Anderson FA, for the GRACE Investigators. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 2002;90:358-63.
2001
  1. The GRACE Investigators. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J 2001;141:190-9.
2000
  1. Fox KAA. An introduction to the Global Registry of Acute Coronary Events: GRACE. Eur Heart J 2000;2(Suppl F):F21-4.
  2. Granger CB. Strategies of patient care in acute coronary syndromes: rationale for the Global Registry of Acute Coronary Events (GRACE) registry. Am J Cardiol 2000;86(Suppl):4M-9M.
‘Expanded’ GRACE (GRACE2) publications
  1. Bagnall AJ, Goodman SG, Fox KAA, Yan RT, Gore JM, Cheema AS, Huynh T, Chauret D, Fitchett DH, Langer A, Yan AT, for the Canadian Acute Coronary Syndrome Registry I and II Investigators and Canadian Global Registry of Acute Coronary Events (GRACE/GRACE2) Investigators. Influence of age on use of cardiac catheterization and associated outcomes in patients with non-ST-elevation acute coronary syndrome. Am J Cardiol 2009: 103:1530-6.
  2. Banihashemi B, Goodman SG, Yan RT, Welsh RC, Mehta SR, Montalescot G, Kornder JM, Wong GC, Gyenes G, Steg PG, Yan AT. Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute coronary syndrome patients: The Canadian Global Registry of Acute Coronary Events (GRACE) experience. Am Heart J. 2009;158:917-924.
  3. Elbarouni B, Goodman SG, Yan RT, Welsh RC, Kornder JM, DeYoung JP, Wong GC, Rose B, Grondin FR, Gallo R, Tan M, Casanova A, Eagle KA, Yan AT, on behalf of the Canadian Global Registry of Acute Coronary Events (GRACE/GRACE2) Investigators. Validation of the GRACE Risk Score for In-Hospital Mortality in Acute Coronary Syndrome Patients in Canada. Am Heart J 2009;158:392-9.
  4. Goodman SG, Huang W, Yan AT, Budaj A, Kennelly BM, Gore JM, Fox KAA, Goldberg RJ, Anderson FA, and for the Expanded Global Registry of Acute Coronary Events (GRACE2) Investigators. The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes. Am Heart J 2009;158:193-201.e5.
  5. Jedrzkiewicz S, Goodman SG, Yan RT, Grondin FR, Gallo R, Welsh RC, Lai K, Huynh T, Yan AT, on behalf of the Canadian Global Registry of Acute Coronary Events (GRACE/GRACE2) Investigators. Evaluation of left ventricular ejection fraction in non-st-segment elevation acute coronary syndromes and its relationship to treatment. Am Heart J 2010 (in press).
  6. Jedrzkiewicz S, Goodman SG, Yan RT, Welsh RC, Kornder J, Paul DeYoung J, Wong GC, Rose B, Grondin FR, Gallo R, Huang W, Gore JM, Yan AT, on behalf of the Canadian Global Registry of Acute Coronary Events (GRACE/GRACE2) Investigators. Temporal Trends in the Use of Invasive Cardiac Procedures for Non-ST-Segment Elevation Acute Coronary Syndromes According to Initial Risk Stratification. Can J Cardiol (in press).
  7. Lee TC, Goodman SG, Yan RT, Grondin FR, Welsh RC, Rose B, Gyenes G, MDf, Zimmerman RH, Brossoit R, Saposnik G, Graham JJ, Yan AT, on Behalf of the Canadian Acute Coronary Syndromes I and II, Canadian Global Registry of Acute Coronary Events (GRACE/GRACE2) and the Canadian Registry of Acute Coronary Events (CANRACE) Investigators. Disparities in Management Patterns and Outcomes of Patients With Non–ST-Elevation Acute Coronary Syndrome With and Without a History of Cerebrovascular Disease. Am J Cardiol 2010;105:1083–1089.
  8. Philippe F, Larrazet F, Dibie A, Bouabdallah K, Carbognani D, Folliguet T, Czitrom D, Lagier A, Laborde F, Cohen A, Montalescot G. [Management of acute coronary syndromes in a new French coronary intensive care unit. The first four years of activity in the GRACE registry (Global Registry of Acute Coronary Events)]. Ann Cardiol Angeiol (Paris). 2005;54(2):68-73.
  9. Rao R, Goodman SG, Yan RT, Spencer FA, Fox KAA, DeYoung JP, Rose R, Grondin FR, Gallo R, Gore JM, and Yan AT, on behalf of the Canadian Global Registry of Acute Coronary Events (GRACE/GRACE2) Investigators. Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes. Am Heart J 2009;157(4): 642-650.
  10. Tebbe U, Bramlage P, von Löwis of Menar P, Lawall H, Gaudron P, Lüders S, Klaus A, Lengfelder W, Scholz KH, Maziejewski S, Cuneo A, Hohmann V, Gulba D. Behandlung des akuten koronarsyndroms in Deutschland: erfahrungen eines deutschen clusters des GRACE-registers. [Treatment of the acute coronary syndrome in Germany: experience in a German cluster of the GRACE registry]. Dtsch Med Wochenschr. 2007 Sep;132(39):2000-5.
  11. Elbarasi E, Goodman SGG, Yan RT, Welsh RC, Kornder J, Wong GC, Déry J-P, Anderson FA, Gore JM, Fox KAA, Yan AT, on behalf of the Canadian Acute Coronary Syndrome Registries I and II (ACS I and ACS II) and Canadian Global Registry of Acute Coronary Events (GRACE/expanded-GRACE) Investigators. Management Patterns of Non-ST Segment Elevation Acute Coronary Syndromes in Relation to Prior Coronary Revascularization. Am Heart J 2009 (in press).
  12. Wong JA, Goodman SG, Yan RT, Wald R, Bagnall AJ, Welsh RC, Wong GC, Kornder J, Eagle KA, Steg PG, Yan AT. Temporal management patterns and outcomes of non-ST elevation acute coronary syndromes in patients with kidney dysfunction. Eur Heart J 2009.
  13. Elbarouni B, Elmanfud O, Yan RT, Fox KAA, Kornder JM, Rose B, Spencer FA, Welsh RC, Wong GC, Goodman SG, Yan AT. Temporal Trend of In-hospital Major Bleeding Among Patients with Non St-elevation Acute Coronary Syndromes. Am Heart J 2010 (in press).
Validation of GRACE risk scores - non-GRACE publications
  1. Alter DA, Venkatesh V, Chong A. Evaluating the performance of the Global Registry of Acute Coronary Events risk-adjustment index across socioeconomic strata among patients discharged from the hospital after acute myocardial infarction. Am Heart J 2006;151:323-331.
  2. Bradshaw PJ, Ko DT, Newman AM, Donovan LR, Tu JV. Validity of the GRACE (Global Registry of Acute Coronary Events) acute coronary syndrome prediction model for six month post-discharge death in an independent data set. Heart 2006;92:905-909.
  3. de Araujo Goncalves P, Ferreira J, Aguiar C, Seabra-Gomes R. TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur Heart J 2005;26:865-872.
  4. Floria, M; Rezus, C; Artenie, R, et al. GRACE risk score in patients with acute coronary syndrome: the practical utility at hospital admission. Acta Cardiolocia 2009:64(1): 133-134
  5. Gale CP, Manda SO, Weston CF, Birkhead JS, Batin PD, Hall AS. Evaluation of risk scores for risk stratification of acute coronary syndromes in the Myocardial Infarction National Audit Project (MINAP) database. Heart. 2009;95:221-227.
  6. Lev EI, Kornowski R, Vaknin-Assa H, Porter A, Teplitsky I, Ben-Dor I, Brosh D, Fuchs S, Battler A, Assali A. Comparison of the predictive value of four different risk scores for outcomes of patients with st-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol. 2008;102:6-11 [query error over analysis]
  7. McLean S, Phillips A, Carruthers K, Fox KAA. Use of the GRACE score by cardiology nurse specialists in the emergency department. Br J Cardiac Nurs 2010;5(2):91-95.
  8. Tang EW, Wong CK, Herbison P. Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. Am Heart J 2007;153:29-35.
  9. Yan AT, Jong P, Yan RT, Tan M, Fitchett D, Chow CM, Roe MT, Pieper KS, Langer A, Goodman SG. Clinical trial--derived risk model may not generalize to real-world patients with acute coronary syndrome. Am Heart J 2004;148:1020-1027.
  10. Yan AT, Yan RT, Tan M, Casanova A, Labinaz M, Sridhar K, Fitchett DH, Langer A, Goodman SG. Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily better. Eur Heart J 2007.
GLOW | GRACE | STAT | DVT.org
GRACE is supported by a grant from sanofi aventis
Copyright 1998-2010 Center for Outcomes Research - University of Massachusetts Medical School
For general questions and information email: GRACE at umassmed.edu or call (508)856-0081